Loading clinical trials...
Loading clinical trials...
Open-label extension study from YKP509C001 to evaluate the safety and tolerability of carisbamate in subjects with Lennox-Gastaut Syndrome (LGS).
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
SK Life Science, Inc.
NCT05066217 · Lennox Gastaut Syndrome
NCT06401538 · Absence Epilepsy, Jeavons Syndrome, and more
NCT05044819 · Lennox Gastaut Syndrome, Dravet Syndrome, and more
NCT05339126 · Epilepsy, Lennox Gastaut Syndrome, and more
NCT06464653 · Lennox Gastaut Syndrome
Johns Hopkins Hospital
Baltimore, Maryland
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire
Oregon Health and Science University
Portland, Oregon
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions